Arxada Names Sanjeev Rastogi CMC President
25 Apr 2023
Executive ChangeMicrobial therapy
Arxada announced that Sanjeev Rastogi has been appointed president of Consumer Microbial Control (CMC). Rastogi will be based in Florham Park, NJ, and serve as a member of the Executive Leadership Team, reporting directly to the company’s CEO, Marc Doyle.
Rastogi joins Arxada from Hexion, where he served as SVP for its Resins business. He has held many diverse leadership roles and gained industry experience during his tenure at Honeywell, where he most recently was the VP, general manager, Fluorine Products, Performance Material and Technologies, with an emphasis on enhancing global sustainability, safety and energy efficiencies.
CMC is Arxada’s largest business, comprising Home & Personal Care, Professional Hygiene and Wood Protection as well as Crop and Water Protection. With its industry-leading science and innovation capabilities, in-depth regulatory know-how and track record in manufacturing and process development, CMC develops and manufactures a broad portfolio of differentiated consumer microbial control products and solutions that addresses the growing need for more sustainable preservation.
“We are delighted to welcome Sanjeev to Arxada as we continue to strengthen our leadership team and enhance our capabilities as an industry leader in consumer-based microbial control end markets,” said Doyle. “Sanjeev’s proven track record in driving sustainable innovation and in building portfolios with a lower climate impact are aligned with our purpose of providing better science to solve the world’s toughest preservation challenges. We welcome his passion for creating a performance-based culture that drives both, business results and employee development.”
“It is with great excitement that I join Arxada at such a pivotal time in the company’s journey,” said Rastogi. “I look forward to contributing my knowledge and experience to raise CMC to a new level, entering new market segments and expanding geographically with a more sustainable, science-driven portfolio of products and solutions.”
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
-Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.